Clinical Trial Update: Markers and Calculation of Cardiovascular Risk in the Distinct Phenotypes of Polycystic Ovary Syndrome

View source ↗

Summary

This clinical trial update discusses biomarkers and calculation of cardiovascular risk across distinct phenotypes of polycystic ovary syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Snippet

Sponsor: Aristotle University Of Thessaloniki | Conditions: Polycystic Ovary Syndrome | Status: UNKNOWN